Pharmaceutical

Filter

Current filters:

None

Popular Filters

46 to 70 of 7181 results

FDA approves third indication for Lilly’s Cyramza

FDA approves third indication for Lilly’s Cyramza

13-12-2014

The US Food and Drug Administration on Friday expanded the approved use of pharma major Eli Lilly’s…

CyramzaEli LillyOncologyPharmaceuticalRegulationUSA

Bayer fails in Indian Nexavar patent appeal

Bayer fails in Indian Nexavar patent appeal

13-12-2014

German pharma major Bayer suffered a significant disappointment on Friday, when India’s Supreme Court…

BayerIndiaLegalNatco PharmaNexavarOncologyPatentsPharmaceutical

Sanofi Pasteur gains FDA approval of Fluzone Intradermal Quadrivalent for adults

Sanofi Pasteur gains FDA approval of Fluzone Intradermal Quadrivalent for adults

13-12-2014

French pharma major Sanofi’s vaccines division, Sanofi Pasteur, has received approval from the US Food…

Anti-viralsFluzonePharmaceuticalRegulationSanofiSanofi PasteurUSAVaccines

Dompé announces promising preliminary data on reparixin in triple negative breast cancer

Dompé announces promising preliminary data on reparixin in triple negative breast cancer

12-12-2014

Italian biopharma company Dompé has conducted the first study looking at the combination of its reparixin…

DompeItalyOncologyPharmaceuticalreparixinResearch

Tamoxifen offers long period of protection against breast cancer but does not reduce mortality

Tamoxifen offers long period of protection against breast cancer but does not reduce mortality

12-12-2014

A study published in The Lancet Oncology and presented at the San Antonio Breast Cancer Symposium showed…

Breast cancerOncologyPharmaceuticalResearchtamoxifen

Merck and NewLink Ebola vaccine trial suspended as patients report joint pain

Merck and NewLink Ebola vaccine trial suspended as patients report joint pain

12-12-2014

Pharma giant Merck & Co’s Phase I trial of Ebola Vaccine VSV-ZEBOV, developed in conjunction with NewLink,…

Anti-viralsMerck & CoNewLink GeneticsPharmaceuticalResearchSwitzerland

Twin Swedish and Welsh life sciences hubs plan to share knowledge

Twin Swedish and Welsh life sciences hubs plan to share knowledge

12-12-2014

A Swedish cluster for life sciences, Medicon Village, visited the new Life Sciences Hub Wales center…

Medicon VillagePharmaceuticalResearchSwedenUK

FDA approves 35 novel drugs in 2014 boosted by breakthrough therapies

FDA approves 35 novel drugs in 2014 boosted by breakthrough therapies

12-12-2014

The US Food and Drug Administration has so far approved 35 novel drugs this year, compared to 27 last…

BlincytoHarvoniPharmaceuticalRegulationUSA

Court tells Actavis it must continue Namenda IR distribution

Court tells Actavis it must continue Namenda IR distribution

12-12-2014

Ireland-headquartered generic drugmaker Actavis confirmed that Judge Robert Sweet of the US District…

ActavisLegalMarkets & MarketingNamendaNeurologicalPharmaceuticalUSA

Big savings on HIV drugs via pooled procurement expected by Global Fund

Big savings on HIV drugs via pooled procurement expected by Global Fund

12-12-2014

The Global Fund to Fight AIDS, Tuberculosis and Malaria is putting into place a new agreement for purchasing…

Anti-viralsFinancialGlobalHealthcarePharmaceuticalPricing

Savings from extended role exceed NZ$100 million, says NZ’s PHARMAC

Savings from extended role exceed NZ$100 million, says NZ’s PHARMAC

12-12-2014

District Health Boards are poised to save more than $100 million over five years as a result of New Zealand’s…

FinancialHealth Medical PharmaHealthcareNew ZealandPharmaceutical

Janssen commits $30 million to USAID agreement to fight antibiotic-resistant bacteria

Janssen commits $30 million to USAID agreement to fight antibiotic-resistant bacteria

12-12-2014

US health care giant Johnson & Johnson’s subsidiary Janssen has made an agreement with the United States…

Antibiotics and Infectious diseasesJanssenPharmaceuticalResearchUSA

Alzheimer's Research UK launches $31 million global clinical trials fund

Alzheimer's Research UK launches $31 million global clinical trials fund

12-12-2014

Alzheimer’s Research UK, the country’s leading dementia research charity, has launched a global clinical…

DementiaNeurologicalPharmaceuticalResearchUK

Santen appoints Paolo Casati as manager of its new Italian operation

Santen appoints Paolo Casati as manager of its new Italian operation

11-12-2014

Ophthalmic specialist Santen has appointed Paolo Casati as general manager of Santen Italy, following…

BoardroomItalyOphthalmicsPharmaceuticalSanten Pharmaceuticals

US FDA issues warning on Pfizer’s Geodon

US FDA issues warning on Pfizer’s Geodon

11-12-2014

The US Food and Drug Administration is warning that the antipsychotic drug ziprasidone (marketed under…

GeodonNeurologicalPfizerPharmaceuticalRegulationUSAZiprasidone

India revisits plans for free generic medicines, drug price fixing

India revisits plans for free generic medicines, drug price fixing

11-12-2014

Government hospitals in India that lack medicines, are overcrowded and understaffed, may soon be a thing…

FinancialGenericsHealthcareIndiaPharmaceuticalPoliticsPricing

Russia’s R-Pharm to invest $50 million in development of new drugs and vaccines

Russia’s R-Pharm to invest $50 million in development of new drugs and vaccines

11-12-2014

R-Pharm, one of Russia’s largest pharmaceutical producers, together with Russian Venture Company (RVC)…

FinancialPharmaceuticalPharmstandardR-PharmResearchRussia

UK industry makes third quarter PPRS payment, Department of Health sets 2015 percentage at 10.36%

UK industry makes third quarter PPRS payment, Department of Health sets 2015 percentage at 10.36%

11-12-2014

The UK pharma industry has made its third quarter payment to underwrite the growth of the medicines bill…

ABPIDepartment of HealthPharmaceuticalRegulationUK

GlaxoSmithKline files for EU extended indication for Volibris in PAH

GlaxoSmithKline files for EU extended indication for Volibris in PAH

11-12-2014

UK pharma major GlaxoSmithKline says it has filed a regulatory submission to the European Medicines Agency…

EuropeGilead SciencesGlaxoSmithKlineLetairisPharmaceuticalRegulationRespiratory and PulmonaryVolibris

Shire exercises option on candidates from arGEN-X collaboration

Shire exercises option on candidates from arGEN-X collaboration

11-12-2014

Ireland-headquartered drugmaker Shire has exercised the option to advance into preclinical development…

arGEN-XLicensingPharmaceuticalResearchShire

Africa will be hardest hit region of anti-microbial resistance, warns report

Africa will be hardest hit region of anti-microbial resistance, warns report

11-12-2014

Low income countries are likely to suffer the greatest loss of population and economic output if anti-microbial…

Antibiotics and Infectious diseasesFinancialPharmaceuticalResearchRest of the WorldSub-Saharan Africa

46 to 70 of 7181 results

Back to top